Attenuated oncolytic reovirus with reduced toxicity
2011

Attenuated reovirus shows reduced toxicity while targeting cancer cells

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kim M, Garant K A, zur Nieden N I, Alain T, Loken S D, Urbanski S J, Forsyth P A, Rancourt D E, Lee P W K, Johnston R N

Primary Institution: University of Calgary

Hypothesis

Can an attenuated form of reovirus maintain its oncolytic potential while reducing toxicity to healthy tissues?

Conclusion

The attenuated reovirus preferentially targets cancer cells and shows reduced toxicity compared to wild-type reovirus, suggesting its potential use in cancer therapy.

Supporting Evidence

  • AV reovirus did not kill healthy stem cells or induce black tail formation in SCID mice.
  • AV reovirus retained its ability to target cancer cells and reduce tumor size.
  • AV reovirus showed significantly reduced pathogenic potential to healthy cells while maintaining oncolytic activity.

Takeaway

A modified virus can attack cancer cells without hurting healthy ones, making it safer for patients.

Methodology

The study involved characterizing an attenuated reovirus through sequence analysis and testing its effects on various cell lines and SCID mice with tumor xenografts.

Limitations

The study primarily focused on specific cell lines and animal models, which may not fully represent human responses.

Participant Demographics

The study involved SCID mice and various human and murine cell lines.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606053

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication